Symbols

RBOT(Delisted)

Vicarious Surgical·NYSE

--(--)

RBOT fundamentals

RBOT Q3 2025 Earnings

Vicarious Surgical (RBOT) released its earnings on Nov 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -1.91 (YoY +33.60%), beat estimates.

Revenue / YoY

EPS / YoY

-1.91

+33.60%

Report date

Nov 12, 2025

RBOT Earnings Call Summary for Q3,2025

2026 Design Freeze On Track: Despite 15% workforce reduction, maintaining clinical trial timelines via targeted outsourcing.
$10M+ Annualized Cost Savings: 35% YoY expense reduction, with 2026 burn target <$40M.
Surgeon-Tested Efficiency: 65% reduction in complex surgical procedures, validating commercial viability.
Transparency Boost: Weekly LinkedIn updates to replace quarterly earnings calls for real-time progress.

Earnings

EPS

Revenue

Revenue & Expenses

Key Indicators

Vicarious Surgical (RBOT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Vicarious Surgical (RBOT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Vicarious Surgical (RBOT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Vicarious Surgical (RBOT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Vicarious Surgical (RBOT) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Vicarious Surgical (RBOT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data